血糖控制不佳是血管手术患者术后并发症和死亡率的强预测因子
该研究回顾性分析了2009至2013年一家大型学术中心的1051例血管手术患者,其中366例(34.8%)存在围术期高血糖(术后72小时内至少一次血糖>180 mg/dL)。高血糖患者30天死亡率(5.7% vs 0.7%,P<.01)及急性肾衰竭、术后卒中、手术部位感染、再入院和再手术率均更高,多变量逻辑回归显示围术期高血糖与30天死亡率增加及多种不良结局强相关。
要点
- 围术期高血糖(血糖>180 mg/dL)见于34.8%的血管手术患者。
- 高血糖患者30天死亡率5.7% vs 0.7%(P<.01),急性肾衰竭4.9% vs 0.9%(P<.01)。
- 高血糖还与术后卒中、手术部位感染、再入院和再手术率升高相关。
核心结论
- 围术期血糖控制与血管手术后30天死亡率及多种其他术后结局存在强关联。
研究设计与样本
- 回顾性综述,纳入2009至2013年一家大型学术中心的血管手术患者数据库,共1051例。
- 纳入手术包括颈动脉内膜切除术和支架置入术、血管内和开放主动脉瘤修复术以及所有开放旁路血运重建手术。
主要发现
- 1051例患者中366例(34.8%)存在围术期高血糖,定义为术后72小时内至少一次血糖值>180 mg/dL。
- 高血糖患者30天死亡率5.7% vs 0.7%(P<.01),急性肾衰竭4.9% vs 0.9%(P<.01)。
- 高血糖患者术后卒中3.0% vs 0.7%(P<.01),手术部位感染5.7% vs 2.6%(P=.01)。
- 高血糖患者再入院12.3% vs 7.9%(P=.02),再手术6.3% vs 1.8%(P<.01)。
- 多变量逻辑回归显示围术期高血糖与30天死亡率增加及心肌梗死、卒中、肾衰竭和伤口并发症等多种不良术后结局强相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hyperglycemia is a common occurrence in patients undergoing cardiovascular surgery. It has been identified in several surgical cohorts that improved perioperative glycemic control reduced postoperative morbidity and mortality. A significant portion of the population with peripheral arterial disease suffers from the sequelae of diabetes or metabolic syndrome. A paucity of data exists regarding the relationship between perioperative glycemic control and postoperative outcomes in vascular surgery patients. The objective of this study was to better understand this relationship and to determine which negative perioperative outcomes could be abated with improved glycemic control. METHODS: This is a retrospective review of a vascular patient database at a large academic center from 2009 to 2013. Eligible procedures included carotid endarterectomy and stenting, endovascular and open aortic aneurysm repair, and all open bypass revascularization procedures. Data collected included standard demographics, outcome parameters, and glucose levels in the perioperative period. Perioperative hyperglycemia was defined as at least one glucose value >180 mg/dL within 72 hours of surgery. The primary outcome was 30-day mortality, with secondary outcomes of complications, need to return to the operating room, and readmission. RESULTS: Of the total 1051 patients reviewed, 366 (34.8%) were found to have perioperative hyperglycemia. Hyperglycemic patients had a higher 30-day mortality (5.7% vs 0.7%; P < .01) and increased rates of acute renal failure (4.9% vs 0.9%; P < .01), postoperative stroke (3.0% vs 0.7%; P < .01), and surgical site infections (5.7% vs 2.6%; P = .01). In addition, these patients were also more likely to undergo readmission (12.3% vs 7.9%; P = .02) and reoperation (6.3% vs 1.8%; P < .01). Furthermore, multivariable logistic regression demonstrated that perioperative hyperglycemia had a strong association with increased 30-day mortality and multiple negative postoperative outcomes, including myocardial infarction, stroke, renal failure, and wound complications. CONCLUSIONS: This study demonstrates a strong association between perioperative glucose control and 30-day mortality in addition to multiple other postoperative outcomes after vascular surgery.
引用
- Long CA, Fang ZB, Hu FY, et al. Poor glycemic control is a strong predictor of postoperative morbidity and mortality in patients undergoing vascular surgery. J Vasc Surg. 2018. PMID: 30459015. doi:10.1016/j.jvs.2018.06.212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。